ADHD in Adults: Recognition, Treatment, and the Evidence Base

Attention-deficit/hyperactivity disorder in adults has received growing recognition over the past several decades, following decades in which ADHD was considered primarily or exclusively a childhood condition. Research now clearly establishes that ADHD frequently persists into adulthood, that many adults with ADHD were not diagnosed as children, and that adult ADHD has significant consequences for occupational functioning, relationships, and wellbeing that can be meaningfully addressed with appropriate treatment. Prevalence of ADHD in adults is estimated at approximately 2 to 5 percent of the adult population globally, though estimates vary depending on diagnostic criteria and assessment methods. The condition shows strong heritability, and many adults are identified when their children are diagnosed and they recognize the symptoms in themselves. Among adults with ADHD, a significant proportion were not identified during childhood, either because their symptoms were not severe enough to prompt evaluation, because the presentations were atypical such as predominantly inattentive presentation in girls and women, or because they compensated effectively enough through adolescence before encountering the demands of adulthood. Adult ADHD presents differently from childhood ADHD in important ways. Hyperactivity, which is prominent in many childhood presentations, tends to become more internalized in adults, manifesting as restlessness, difficulty sitting still in situations where quiet is expected, or a subjective sense of being driven by a motor rather than the observable physical activity of childhood. Inattention, including difficulty sustaining attention, poor organization, forgetfulness, and difficulty completing tasks, tends to be more prominent in adult presentations and more impairing in the demands of adult work and daily functioning. The consequences of untreated adult ADHD across multiple life domains are well-documented. Research finds higher rates of job loss and underemployment, more frequent relationship difficulties including higher divorce rates, higher rates of traffic accidents and speeding violations, greater financial difficulties, higher rates of substance use disorders, and worse educational and occupational outcomes compared to adults without ADHD. These consequences are attributable to the core executive function deficits of ADHD rather than to secondary factors, meaning that effective treatment can meaningfully improve outcomes. Diagnosis of ADHD in adults requires careful clinical evaluation that considers current symptoms, developmental history, evidence of impairment, and differential diagnosis. The diagnosis is based on clinical interview, rating scales, and collateral information when available. Neuropsychological testing can be a useful supplement but is not required for diagnosis and does not by itself confirm or rule out ADHD. Adult ADHD often co-occurs with other conditions including depression, anxiety, substance use disorders, and learning disabilities, which can complicate both diagnosis and treatment. Stimulant medications, including methylphenidate and amphetamine-based medications, are the most effective pharmacological treatments for ADHD in adults, with a strong evidence base from multiple randomized controlled trials. Non-stimulant medications including atomoxetine, bupropion, and guanfacine are alternatives for adults who do not respond to or cannot tolerate stimulants. Research consistently finds that medication produces meaningful improvements in attention, organization, and impulse control, with large effect sizes in randomized trials. Psychosocial treatments for adult ADHD, including cognitive behavioral therapy adapted for ADHD, skills training in organization, time management, and planning, and coaching approaches, have accumulated an evidence base showing benefits that complement medication effects. CBT for adult ADHD targets the cognitive patterns, avoidance behaviors, and skill deficits that contribute to functional impairment beyond the neurobiological symptoms addressed by medication. Combination of medication and behavioral approaches shows stronger outcomes than either alone for adults with moderate to severe impairment. The diagnosis of ADHD in adults has grown significantly as awareness has increased, and with it concerns about overdiagnosis and about the misuse of prescribed stimulants. Research on ADHD diagnosis trends and stimulant prescribing documents substantial growth over the past two decades. The appropriate clinical response to these concerns is careful diagnostic evaluation rather than diagnostic skepticism that leaves genuinely affected adults without treatment they need.